{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:58:14Z","timestamp":1787245094465,"version":"build-2736575974"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T00:00:00Z","timestamp":1623196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T00:00:00Z","timestamp":1623196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>There are no pharmacological interventions currently available to prevent the transmission of SARS-CoV-2 or to treat COVID-19. The development of vaccines against COVID-19 is essential to contain the pandemic. we conducted a cross-sectional survey of Shanghai residents to understand residents\u2019 willingness to be vaccinated with any future COVID-19 vaccines and take measures to further improve vaccination coverage.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We conducted a cross-sectional survey using self-administered anonymous questionnaires from 1 July to 8 September 2020. The main outcome was willingness of participants, and any children or older individuals living with them, to receive future COVID-19 vaccines. Logistic regression analyses were used to explore potential factors associated with vaccination willingness.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 1071 participants were asked about their willingness to receive future COVID-19 vaccines, for themselves and at least 747 children and 375 older individuals (\u226560\u2009years old) living with them. The highest proportion of expected willingness to vaccinate was among participants (88.6%), followed by children (85.3%) and older individuals (84.0%). The main reasons for reluctance to vaccinate among 119 participants were doubts regarding vaccine safety (60.0%) and efficacy (28.8%). Participants with a self-reported history of influenza vaccination were more likely to accept COVID-19 vaccines for themselves [adjusted odds ratio (<jats:italic>OR<\/jats:italic>)\u2009=\u20091.83; 95% confidence interval (<jats:italic>CI<\/jats:italic>): 1.19\u20132.82], their children (adjusted <jats:italic>OR<\/jats:italic>\u2009=\u20092.08; 95%<jats:italic>CI<\/jats:italic>: 1.30\u20133.33), and older individuals in their household (adjusted <jats:italic>OR<\/jats:italic>\u2009=\u20092.12; 95%<jats:italic>CI<\/jats:italic>: 1.14\u20133.99). Participants with older individuals in their families were less willing to vaccinate themselves (adjusted <jats:italic>OR<\/jats:italic>\u2009=\u20090.59; 95%<jats:italic>CI<\/jats:italic>: 0.40\u20130.87) and their children (adjusted <jats:italic>OR<\/jats:italic>\u2009=\u20090.58; 95%<jats:italic>CI<\/jats:italic>: 0.38\u20130.89).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Participants were more reluctant to accept COVID-19 vaccines for older individuals living with them. The presence of older individuals in the home also affected willingness of participants and their children to be vaccinated.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12889-021-11174-0","type":"journal-article","created":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T15:04:10Z","timestamp":1623251050000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Willingness to receive future COVID-19 vaccines following the COVID-19 epidemic in Shanghai, China"],"prefix":"10.1186","volume":"21","author":[{"given":"Yehong","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang-Song","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,9]]},"reference":[{"key":"11174_CR1","unstructured":"World Health Organization. Coronavirus disease (COVID-19) Weekly Epidemiological Update and Weekly Operational Update. 2020."},{"key":"11174_CR2","doi-asserted-by":"publisher","unstructured":"Uddin M, Mustafa F, Rizvi TA, Loney T, Suwaidi HA, Al-Marzouqi AHH, et al. SARS-CoV-2\/COVID-19: viral genomics, epidemiology, vaccines, and therapeutic interventions. Viruses. 2020;12(5). https:\/\/doi.org\/10.3390\/v12050526.","DOI":"10.3390\/v12050526"},{"key":"11174_CR3","doi-asserted-by":"crossref","unstructured":"Yoosefi Lebni J, Abbas J, Moradi F, Salahshoor MR, Chaboksavar F, Irandoost SF, et al. How the COVID-19 pandemic effected economic, social, political, and cultural factors: a lesson from Iran. Int J Soc Psychiatry. 2020;20764020939984.","DOI":"10.1177\/0020764020939984"},{"key":"11174_CR4","doi-asserted-by":"publisher","unstructured":"Renzaho AMN. The need for the right socio-economic and cultural fit in the COVID-19 response in sub-Saharan Africa: examining demographic, economic political, health, and socio-cultural differentials in COVID-19 morbidity and mortality. Int J Environ Res Public Health. 2020;17(10). https:\/\/doi.org\/10.3390\/ijerph17103445.","DOI":"10.3390\/ijerph17103445"},{"key":"11174_CR5","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ijsu.2020.04.018","volume":"78","author":"M Nicola","year":"2020","unstructured":"Nicola M, Alsafi Z, Sohrabi C, Kerwan A, Al-Jabir A, Iosifidis C, et al. The socio-economic implications of the coronavirus pandemic (COVID-19): a review. Int J Surg. 2020;78:185\u201393. https:\/\/doi.org\/10.1016\/j.ijsu.2020.04.018.","journal-title":"Int J Surg"},{"issue":"52","key":"11174_CR6","doi-asserted-by":"publisher","first-page":"8131","DOI":"10.1016\/j.vaccine.2018.10.005","volume":"36","author":"W Yu","year":"2018","unstructured":"Yu W, Lee LA, Liu Y, Scherpbier RW, Wen N, Zhang G, et al. Vaccine-preventable disease control in the People's Republic of China: 1949-2016. Vaccine. 2018;36(52):8131\u20137. https:\/\/doi.org\/10.1016\/j.vaccine.2018.10.005.","journal-title":"Vaccine."},{"key":"11174_CR7","unstructured":"Jia Y. Here\u2019s the visual proof of why vaccines do more good than harm. Science: Science; 2017."},{"key":"11174_CR8","unstructured":"World Health Organization. Draft landscape of COVID-19 candidate vaccines. 2020."},{"issue":"10240","key":"11174_CR9","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1016\/S0140-6736(20)31208-3","volume":"395","author":"FC Zhu","year":"2020","unstructured":"Zhu FC, Li YH, Guan XH, Hou LH, Wang WJ, Li JX, et al. Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial. Lancet. 2020;395(10240):1845\u201354. https:\/\/doi.org\/10.1016\/S0140-6736(20)31208-3.","journal-title":"Lancet."},{"issue":"10249","key":"11174_CR10","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S0140-6736(20)31605-6","volume":"396","author":"FC Zhu","year":"2020","unstructured":"Zhu FC, Guan XH, Li YH, Huang JY, Jiang T, Hou LH, et al. Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet. 2020;396(10249):479\u201388. https:\/\/doi.org\/10.1016\/S0140-6736(20)31605-6.","journal-title":"Lancet."},{"key":"11174_CR11","first-page":"1","volume":"80","author":"H Tu","year":"2020","unstructured":"Tu H, Tu S, Gao S, Shao A, Sheng J. Current epidemiological and clinical features of COVID-19; a global perspective from China. J Inf Secur. 2020;80:1\u20139.","journal-title":"J Inf Secur"},{"key":"11174_CR12","unstructured":"Chinese Center for Disease Control and Prevention. COVID-19 column. 2020."},{"issue":"34","key":"11174_CR13","doi-asserted-by":"publisher","first-page":"5424","DOI":"10.1016\/j.vaccine.2020.06.068","volume":"38","author":"LY Garcia","year":"2020","unstructured":"Garcia LY, Cerda AA. Contingent assessment of the COVID-19 vaccine. Vaccine. 2020;38(34):5424\u20139. https:\/\/doi.org\/10.1016\/j.vaccine.2020.06.068.","journal-title":"Vaccine."},{"key":"11174_CR14","doi-asserted-by":"crossref","unstructured":"Dodd RH, Cvejic E, Bonner C, Pickles K, KJ MC. Sydney Health Literacy Lab C-g. Willingness to vaccinate against COVID-19 in Australia. Lancet Infect Dis. 2020.","DOI":"10.1016\/S1473-3099(20)30559-4"},{"key":"11174_CR15","doi-asserted-by":"crossref","unstructured":"Neumann-B\u00f6hme S, Varghese NE, Sabat I, Barros PP, Brouwer W, van Exel J, et al. Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19. Eur J Health Econ. 2020:1\u20136.","DOI":"10.1007\/s10198-020-01208-6"},{"key":"11174_CR16","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/S1473-3099(20)30426-6","volume":"20","author":"The Coconel Group","year":"2020","unstructured":"The Coconel Group. A future vaccination campaign against COVID-19 at risk of vaccine hesitancy and politicisation. Lancet Infect Dis. 2020;20:769\u201370.","journal-title":"Lancet Infect Dis"},{"key":"11174_CR17","doi-asserted-by":"publisher","first-page":"197","DOI":"10.2147\/IDR.S23174","volume":"4","author":"T Nguyen","year":"2011","unstructured":"Nguyen T, Henningsen KH, Brehaut JC, Hoe E, Wilson K. Acceptance of a pandemic influenza vaccine: a systematic review of surveys of the general public. Infect Drug Resist. 2011;4:197\u2013207. https:\/\/doi.org\/10.2147\/IDR.S23174.","journal-title":"Infect Drug Resist"},{"issue":"21","key":"11174_CR18","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1001\/jama.2020.7878","volume":"323","author":"TV Inglesby","year":"2020","unstructured":"Inglesby TV. Public health measures and the reproduction number of SARS-CoV-2. JAMA. 2020;323(21):2186\u20137. https:\/\/doi.org\/10.1001\/jama.2020.7878.","journal-title":"JAMA."},{"key":"11174_CR19","doi-asserted-by":"crossref","unstructured":"Zhu Y, Chen YQ. On a statistical transmission model in analysis of the early phase of COVID-19 outbreak. Stat Biosci. 2020:1\u201317.","DOI":"10.1007\/s12561-020-09277-0"},{"issue":"7","key":"11174_CR20","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.3201\/eid2607.200282","volume":"26","author":"S Sanche","year":"2020","unstructured":"Sanche S, Lin YT, Xu C, Romero-Severson E, Hengartner N, Ke R. High contagiousness and rapid spread of severe acute respiratory syndrome coronavirus 2. Emerg Infect Dis. 2020;26(7):1470\u20137. https:\/\/doi.org\/10.3201\/eid2607.200282.","journal-title":"Emerg Infect Dis"},{"issue":"7","key":"11174_CR21","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/j.vaccine.2011.12.089","volume":"30","author":"S Brien","year":"2012","unstructured":"Brien S, Kwong JC, Buckeridge DL. The determinants of 2009 pandemic A\/H1N1 influenza vaccination: a systematic review. Vaccine. 2012;30(7):1255\u201364. https:\/\/doi.org\/10.1016\/j.vaccine.2011.12.089.","journal-title":"Vaccine."},{"issue":"1","key":"11174_CR22","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1471-2334-11-128","volume":"11","author":"Y Lin","year":"2011","unstructured":"Lin Y, Huang L, Nie S, Liu Z, Yu H, Yan W, et al. Knowledge, attitudes and practices (KAP) related to the pandemic (H1N1) 2009 among Chinese general population: a telephone survey. BMC Infect Dis. 2011;11(1):128. https:\/\/doi.org\/10.1186\/1471-2334-11-128.","journal-title":"BMC Infect Dis"},{"key":"11174_CR23","doi-asserted-by":"crossref","unstructured":"Matrajt L, Eaton J, Leung T, Brown ER. Vaccine optimization for COVID-19, who to vaccinate first? medRxiv. 2020.","DOI":"10.1101\/2020.08.14.20175257"},{"key":"11174_CR24","first-page":"e16","volume":"81","author":"Z Zheng","year":"2020","unstructured":"Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J, et al. Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis. J Inf Secur. 2020;81:e16\u201325.","journal-title":"J Inf Secur"},{"key":"11174_CR25","doi-asserted-by":"publisher","first-page":"343","DOI":"10.15585\/mmwr.mm6912e2","volume":"69","author":"CC-R Team","year":"2020","unstructured":"Team CC-R. Severe outcomes among patients with coronavirus disease 2019 (COVID-19) - United States, February 12-March 16, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:343\u20136.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"11174_CR26","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1016\/j.jinf.2020.04.018","volume":"81","author":"R Song","year":"2020","unstructured":"Song R, Han B, Song M, Wang L, Conlon CP, Dong T, et al. Clinical and epidemiological features of COVID-19 family clusters in Beijing, China. J Infect. 2020;81(2):e26\u201330. https:\/\/doi.org\/10.1016\/j.jinf.2020.04.018.","journal-title":"J Infect"},{"issue":"47","key":"11174_CR27","doi-asserted-by":"publisher","first-page":"5724","DOI":"10.1016\/j.vaccine.2016.10.013","volume":"34","author":"J Yang","year":"2016","unstructured":"Yang J, Atkins KE, Feng L, Pang M, Zheng Y, Liu X, et al. Seasonal influenza vaccination in China: landscape of diverse regional reimbursement policy, and budget impact analysis. Vaccine. 2016;34(47):5724\u201335. https:\/\/doi.org\/10.1016\/j.vaccine.2016.10.013.","journal-title":"Vaccine."},{"issue":"9","key":"11174_CR28","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1001\/jamapediatrics.2020.1467","volume":"174","author":"R Castagnoli","year":"2020","unstructured":"Castagnoli R, Votto M, Licari A, Brambilla I, Bruno R, Perlini S, et al. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents: a systematic review. JAMA Pediatr. 2020;174(9):882\u20139. https:\/\/doi.org\/10.1001\/jamapediatrics.2020.1467.","journal-title":"JAMA Pediatr"},{"key":"11174_CR29","unstructured":"Committee of the National People\u2019s Congress. Law of the People\u2019s Republic of China on Vaccine Administration. 2019."},{"key":"11174_CR30","unstructured":"China Central Television Finance Channel. China COVID-19 Vaccine Pioneers. 2020. p. August 22, 2020."},{"issue":"34","key":"11174_CR31","doi-asserted-by":"publisher","first-page":"5396","DOI":"10.1016\/j.vaccine.2020.06.058","volume":"38","author":"W Henn","year":"2020","unstructured":"Henn W. Allocation criteria for an initial shortage of a future SARS-CoV-2 vaccine and necessary measures for global immunity. Vaccine. 2020;38(34):5396\u20137. https:\/\/doi.org\/10.1016\/j.vaccine.2020.06.058.","journal-title":"Vaccine."},{"issue":"4","key":"11174_CR32","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.vaccine.2017.12.008","volume":"36","author":"S Wu","year":"2018","unstructured":"Wu S, Su J, Yang P, Zhang H, Li H, Chu Y, et al. Willingness to accept a future influenza A(H7N9) vaccine in Beijing, China. Vaccine. 2018;36(4):491\u20137. https:\/\/doi.org\/10.1016\/j.vaccine.2017.12.008.","journal-title":"Vaccine"},{"issue":"9","key":"11174_CR33","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/s41422-020-0371-0","volume":"30","author":"W Liang","year":"2020","unstructured":"Liang W, Lin Y, Bi J, Li J, Liang Y, Wong SS, et al. Serosurvey of SARS-CoV-2 among hospital visitors in China. Cell Res. 2020;30(9):817\u20138. https:\/\/doi.org\/10.1038\/s41422-020-0371-0.","journal-title":"Cell Res"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-021-11174-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-021-11174-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-021-11174-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T15:06:30Z","timestamp":1623251190000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-021-11174-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,9]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["11174"],"URL":"https:\/\/doi.org\/10.1186\/s12889-021-11174-0","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,9]]},"assertion":[{"value":"30 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All of the authors declared no conflict of interests. There is no financial support for this project.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Review Board of Xuhui District Center for Disease Control and Prevention (No. XHCDC202001). Informed consent from participants was obtained prior to scanning the QR code to complete the questionnaire. Anonymity was guaranteed to participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1103"}}